Welcome to the DZIF -

the German Center for Infection Research

Information on SARS-CoV-2

Visit page

Research Areas

DZIF is doing research in nine areas:


News and Press Releases.

Dr. Silvia Portugal im Heidelberger Labor
© Universitätsklinikum Heidelberg
Christoph Lange vor Röntgenbildern
© Forschungszentrum Borstel

Milestone in the prevention of tuberculosis

Based on data involving more than 80,000 patients, an international research group has developed a programme that can predict the individual risk of tuberculosis. The results of this work were
© Hyttalo Souza

First volunteers receive COVID-19 vaccine in phase I clinical trial

The vaccine trial is on track. Last Friday, on 9 October, the first test subject was injected with the vaccine MVA-SARS-2-S against COVID-19. A total of six volunteers received the vector vaccine to
Resistenzgene nachweisen
© JLU Gießen

Learning lessons from the coronavirus pandemic on containing other infections

Healthcare-associated infections have been growing continuously for years, resulting in hundreds of thousands of avoidable deaths each year. The main culprit is bacteria that have become resistant to
idt Abfüllanlage
© Hartmut Bösener/IDT Biologika

First clinical trial of DZIF vaccine against COVID-19 gets go-ahead

The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, today approved the clinical trial of the MVA-SARS-2-S vaccine against COVID-19. The vector vaccine was developed by

Up-to-date information and behaviour rules

Coronavirus info


Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Pipetting aid
© Fabian Grein/DZIF
image jpeg (1.16 MB)

Pipetting aid

jpeg (1.16 MB)

Research in Focus

Our Partner Sites

Databases- & Biobanks 2019